Articles for March 2017

Wireless Arm Patch May Blunt Migraine Pain

Wireless Arm Patch Might Blunt Migraine Pain

WEDNESDAY, March 1, 2017 (HealthDay News)– A cordless arm patch might be a promising new treatment for migraine headaches, researchers report. Rubber electrodes and a chip in the spot produce electrical impulses that obstruct pain signals from reaching the brain, the study authors said. When a migraine begins, you can manage the strength of the electrical impulses utilizing a smart device app, explained lead scientist Dr. David Yarnitsky, chair of neurology at Rambam Medical Center, in Haifa, Israel. “You can utilize skin stimulation at an intensity which is not unpleasant and have the ability to stop or significantly diminish the development of a migraine attack, as long as you do it early enough in the migraine attack,” he stated. “There are no side effects,” Yarnitsky included. “You feel a tingle in your upper arm.” Before, when stimulation gadgets had actually been tested on migraines, they needed wires and were attached to the head, Yarnitsky stated. He is an expert to Theranica Ltd., the company that makes the gadget and funded the study. Yarnitsky stated a trial with nearly 200 clients is about to begin, and he hopes by next year that the device will be up for approval by the U.S. Fda. “…

See all stories on this subject Prez Akufo-Addo calls for Cuban assistance to combat

malaria And as part of the Cuban Medical Brigade, Mr Despaign said there were hundreds of Cuban doctors working in the country … Mr Despaign also stated Cuba was relying on the assistance of Ghana in helping to raise the commercial, financial and monetary embargo …

Center to host Gala to Defy Dyslexia on March 11

Center to host Gala to Defy Dyslexia on March 11

WHITESBORO– The Children’s Dyslexia Center of Central New york city is hosting its third annual Gala to Defy Dyslexia. This year’s style is “Reading Is Magic” and will feature home entertainment by local magician Jim Lutz and DJ John Sallustio. The fundraising event is March 11 at the Hart’s Hill Inn, 135 Clinton St., Whitesboro. Mixed drink hour is at 6 p.m. Tickets are $50 an individual and $90 for couples. To find out more, call -LRB-315-RRB- 736-0576 … See all stories on this topic

Bad Diet in Youth May Up Early Breast Cancer Threat

Research study discovered an association, but didn’t show unhealthy foods triggered illness THURSDAY, March 2, 2017 (HealthDay News)– A bad diet plan while young might do more than just make it tough to fit into a set of jeans: New research suggests it might also raise a younger lady’s danger for breast cancer. “A diet plan high in sugar, improved carbohydrates, and red and processed meat makes it most likely that you might experience early beginning breast cancer,” stated research study senior author Karin Michels. She is chair of public health at the UCLA Fielding School of Public Health, in Los Angeles. An unhealthy diet appeared to increase that threat by more than one-third, but the findings can’t prove cause-and-effect, Michels said. “We are talking about a link or association,” she noted. The research study tracked information from more than 45,000 females registered in the Nurses’ Health Study II. All the ladies completed food frequency questionnaires about their teenager and early adult diet plans, and were followed up for 22 years. The researchers designated the diets an inflammatory rating, based on a method that links diet plan with established inflammatory markers in the blood. Eating a high-sugar, refined carb diet has been linked to high …

Poor diet during teens, early adulthood may raise breast cancer risk

Poor diet plan throughout teens, early the adult years may raise breast cancer risk

Previous studies have associated an unhealthy diet plan – particularly one that is low in vegetables, high in refined sugar and carbs, and high in red and processed meats – with chronic swelling, which may raise the risk of particular cancers. Inning accordance with the brand-new study, it is this diet-induced swelling that may increase a lady’s threat of breast cancer prior to menopause. Research study co-author Karin B. Michels, Ph.D. – professor and chair of the Department of Public health at the Fielding School of Public Health at the University of California-Los Angeles – and associates recently reported their findings in the journal Cancer Public health, Biomarkers & Avoidance. After skin cancer, breast cancer is the most typical cancer among ladies in the United States. This year, around 252,710 brand-new cases of invasive breast cancer will be identified, and more than 40,000 females will die from the illness. “About 12 percent of females in the United States establish breast cancer in their lifetimes,” keeps in mind Michels. “Nevertheless, each female’s breast cancer threat is different based upon numerous aspects, consisting of hereditary predisposition, demographics, and lifestyle.” For this most current research study, Michels and coworkers set ou …
See all stories on this topic

Study: Bleeding Risk From Common Blood Thinners

Research study: Bleeding Threat From Typical Blood Thinners

Research looked specifically at bleeds inside the skull and near the brain TUESDAY, Feb. 28, 2017 (HealthDay News)– Blood thinners can assist avoid unsafe clots, but they likewise feature dangers for excess bleeding. Now, brand-new research reveals that usage of the medications does enhance the odds of “subdural hematomas”– bleeds taking place within the skull and near the brain. And some blood slimmers carry greater danger than others. The Danish research group worried that the outcomes don’t mean clients who need blood slimmers should prevent them altogether– just that their data contributes to decisions around their use. “Today data include one more piece of evidence to the complex risk-benefit formula of [blood thinner] use,” composed a group led by Dr. David Gaist, of Odense University Hospital and the University of Southern Denmark. Regardless of the bleeding threat, “it is known that these drugs result in net benefits in general in patients with clear healing indications,” the study authors added. In the study, Gaist’s team tracked data on more than 10,000 Danish clients, aged 20 to 89, who were diagnosed with a first-ever subdural hematoma in between 2000 and 2015. The private investigators then compared that gr …

See all stories on this topic Hip Fracture’s Connect to Early Death Might Ins 2015

People over 60 face two to three times the threat of passing away over next 8 years, study discovers MONDAY, Feb. 27, 2017 (HealthDay News)– Older individuals who suffer a hip fracture deal with a much greater threat of death right after the injury, but the risk continues over the longer term, a big study shows. Scientists discovered that the risk of death amongst individuals over 60 almost tripled throughout the first year following a hip fracture. However, hip fractures were likewise still linked to a nearly twofold increased risk of dying eight years or more after the injury. The new findings are similar to those of previous research studies on hip fracture, said research study lead author Michail Katsoulis. He’s a medical statistician with the Hellenic Health Structure in Athens, Greece. Katsoulis noted that “post-operative problems, such as heart and pulmonary ones, have been mostly linked for the excess short-term death after the fracture, that is within the very first year after.” Those issues consisted of both blood clots and pneumonia. The study cannot definitively show a cause-and-effect relationship. But Katsoulis suspects that older hip fracture patients “are unlikely to remain physically active and most likely …

See all stories on this topic Gene Treatment Reveals Pledge for Aggressive Lymphoma

Over one-third of patients appeared disease-free 6 months after single treatment, report says TUESDAY, Feb. 28, 2017 (HealthDay News)– An experimental gene therapy for aggressive non-Hodgkin lymphoma beat back more than a 3rd of cancers that seemed untreatable, the therapy’s developers report. Thirty-six percent of over 100 very ill lymphoma clients appeared disease-free 6 months after a single treatment, according to results launched by the treatment’s maker, Kite Pharma of Santa Monica, Calif. These clients had not responded to typical treatments and had no other alternatives, Kite said Tuesday in a press release. Overall, more than four from five clients with the blood cancer saw their cancer minimized by over half for a minimum of part of the study, the company stated. “This appears amazing … exceptionally motivating,” one cancer professional, Dr. Roy Herbst, told the Associated Press. But Herbst, who is chief of medical oncology at Yale Cancer Center in New Haven, Conn., said longer follow-up is needed to see if the advantage continues. Still, he said, “This certainly is something I would wish to have offered.” Negative effects, which had been an issue, seemed workable in this research study, he said. The therapy– called CAR-T cell treatment– allows the client’s own blood cells to kill the cancer cells. Lymphoma is a general term for cancers that start in the lymph system. The lymph system belongs to the body immune system, which helps the body battle illness. Here’s how the treatment works: A patient’s blood is filtered so immune cells called T-cells can be become include a cancer-fighting gene. The cells are gone back to the patient intravenously, and the cancer-targeting cells then multiply in the client’s body. The United States National Cancer Institute developed the gene approach and accredited it to Kite. Now, Kite and another pharmaceutical giant, Novartis AG, are contending to get approval of the treatment, inning accordance with the AP. Kite supposedly means to look for U.S. Food and Drug Administration approval this spring and approval in Europe later on this year. It might be the very first gene treatment approved in the United States, the news report kept in mind. Although the treatment appears to benefit a substantial number of clients, it is not risk-free. Researchers believe two patients passed away of treatment-related causes, the AP reported. Opposite impacts consisted of anemia or other blood issues that were treated, and neurological problems such as sleepiness, confusion, trembling or difficulty speaking, which normally lasted just a couple of days, the wire service reported. Overall, however, the treatment appears safe, according to Dr. Steven Rosenberg, chief of surgical treatment branch at the National Cancer Institute. He was not involved with the research study. “It’s a safe treatment, definitely a lot more secure than having progressive lymphoma,” Rosenberg told the AP. He stated he has a client who was treated in this manner who is still in remission seven years later. The expense of such treatment hasn’t been reported yet, but immune system therapies have the tendency to be extremely expensive. The outcomes are set up for presentation at the American Association for Cancer Research conference in April. Till published in a peer-reviewed medical journal, the information and conclusions must be considered initial.

Screening high-risk women may reduce risk of advanced ovarian cancer diagnosis

Screening high-risk females might lower danger of advanced ovarian cancer medical diagnosis

The results of the UK Familial Ovarian Cancer Screening Research study (UK FOCSS), which is led by UCL, reveal that screening ladies at high threat of ovarian cancer every 4 months may minimize the likelihood of them being detected with innovative cancer. It stays uncertain whether finding ovarian cancer by screening increases the chances of a woman surviving the illness. For females at high threat, the present medical advice is to have their ovaries and fallopian tubes eliminated after having actually completed their households, but numerous ladies hold-up or decide versus having the surgery. The UK FOCSS results, released in the Journal of Clinical Oncology, suggest that four month-to-month screening with the Threat of Ovarian Cancer Algorithm (ROCA) might be an alternative for these females till they choose to go through surgical treatment. The algorithm is utilized to try to find increasing levels of a blood protein, CA 125, which can be raised in ovarian cancer. Over 4,000 ladies with a 1 in 10 or higher risk of establishing ovarian cancer due to family history or a faulty gene, participated in the research study after decreasing surgery. A significant percentage of these cancers occur prior to the age of 50 but numerous females are keen to delay surgery till they hav …

See all stories on this subject Never far too late: Profiting of workout in early postmenopause

Ladies recently postmenopause have similar or enhanced benefits from physical activity, in terms of muscle and blood vessel function, as those premenopause. For that reason, early postmenopause may be a time when women can acquire increased benefit from exercise to oppose negative effects of oestrogen loss and aging. This research, released in the Journal of Physiology, was carried out by Professor Hellsten and her group at the University of Copenhagen. Postmenopausal women are deprived of oestrogen, a hormonal agent with a strong positive effect on muscle and blood vessel function. Previous research study had shown that the advantageous impact of physical activity is lowered or missing in postmenopausal ladies. This research recommends that the results of different stages of menopause on exercise can not be lumped together. The individuals were 36 middle-aged pre and postmenopausal ladies only a few years apart in age. After a 12-week training regimen of high intensity biking, Professor Hellsten and her associates determined the effect of training on the females’s muscles and capillary utilizing a series of physiological tests. To take a look at molecular changes, they took tissue samples from thigh …